NEW YORK, Oct. 23 - Proteomics and pharmacogenomics firm Aspira Biosystems has won a Small Business Innovation Research grant from the National Institutes of Health, the company said on Tuesday.

According to South San Francisco, Calif.-based Aspira, the $108,000 award will help it develop a sequence-specific protein chip based on its ProteinPrint technology. This technology, the company said, allows researchers to create “synthetic cavities” that recognize and bind to specific amino-acid sequences.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.